Breakfast seminar: Opportunities & insights from Japan’s life Science market with Business Sweden

Did you know life science accounts for nearly 25% of Sweden’s exports to Japan? Japan’s sophisticated healthcare system remains a key market for 🇸🇪 Swedish life science companies – from established players like AstraZeneca and Getinge to innovators like Sobi - Swedish Orphan Biovitrum AB (publ) and SyntheticMR. Strategic partnerships, such as BioArctic–Eisai and Cantargia AB–Otsuka, highlight the growing potential for biotech collaboration.

Join us for a breakfast seminar to explore how your life science company can thrive in one of the world’s most dynamic life science markets.

Japan’s advanced healthcare system offers strong potential for Swedish life science innovators – from established companies to fast-growing SMEs. With life sciences representing nearly 25% of Sweden’s exports to Japan, the market is open for new partnerships and expansion.

The seminar covers:
– Key trends shaping Japan’s pharma, medtech, biotech & digital health sectors
– Concrete opportunities for Swedish companies
– Guidance on market entry & expansion from Business Sweden lifescience team in Japan: Magnus Blondell and Carsten Grönblad
– Plans for Nordic Health Summit Japan, April 2026

SIGN UP FOR THIS EVENT

Don’t miss this chance to explore how your company can thrive in one of the world’s most dynamic life science markets.

Register by 17 November by emailing christina.wenglen@skane.se